Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul-Sep;18(3):298-302.
doi: 10.4103/0972-2327.160084.

Sleep changes during prophylactic treatment of migraine

Taşkın Duman  1 , Özlem H Dede  1 , Derya Uluduz  2 , Gülşah Seydaoğlu  1 , Esra Okuyucu  1 , İsmet Melek  1
Affiliations

Sleep changes during prophylactic treatment of migraine

Taşkın Duman et al. Ann Indian Acad Neurol. 2015 Jul-Sep.

Abstract

Aims: To assess sleep quality in patients with primary headaches before and after prophylactic treatment using a validated sleep-screening instrument.

Materials and methods: A total of 147 patients, including 63 tension type headache (TTH) and 84 migraine patients were included. Patients were examined in terms of frequency and severity of headaches and sleep quality before and 12 weeks after prophylactic treatment with either propranolol or amitriptyline.

Results: Baseline Visual Analogue Score (VAS) in migraine patients was 7.99 ± 1.39 compared with 6.86 ± 1.50 in TTH group (P < 0.001). VAS score after the first month of treatment was 6.08 ± 1.88 in migraine patients and 5.40 ± 1.61 in TTH (P = 0.023). VAS scores decreased after the third month of treatment to 4.32 ± 2.29 in migraine patients and 4.11 ± 1.66 in TTH patients (P = 0.344). The decrease was significant for patients treated with amitriptyline but not for those with propranolol. Baseline Pittsburgh Sleep Quality (PSQI) scores were 5.93 ± 2.43 in migraine patients and 6.71 ± 2.39 in TTH patients. Poor quality of sleep (PSQI ≥ 6) prior to prophylactic treatment was observed in 61.4% of migraine patients and in 77.7% of TTH patients. Comparison of PSQI scores before and 3 months following treatment showed significantly improved quality of sleep in all treatment groups; the greatest significance was detected in migraine patients with initial PSQI scores of ≥6 and treated with amitriptyline (P < 0.001).

Conclusions: Increased understanding of routine objective sleep measures in migraine patients is needed to clarify the nature of sleep disturbances associated with primary headaches. This may in turn lead to improvements in headache treatments.

Keywords: Migraine; prophylactic treatment; sleep quality.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

References

    1. Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012;15:S15–22. - PMC - PubMed
    1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia. 2013;33:629–808. - PubMed
    1. Pearce J. Insulin induced hypoglycaemia in migraine. J Neurol Neurosurg Psychiatry. 1971;34:154–6. - PMC - PubMed
    1. Rao NS, Pearce J. Hypothalamic-pituitary-adrenal axis studies in migraine with special reference to insulin sensitivity. Brain. 1971;94:289–98. - PubMed
    1. Gasparini CF, Sutherland HG, Griffiths LR. Studies on the pathophysiology and genetic basis of migraine. Curr Genomics. 2013;14:300–15. - PMC - PubMed